This article is more than 5 years old. Information may no longer be current.

First Argentinian patient receives EyeMax Mono lens for AMD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The first EyeMax Mono lens implant procedure for age-related macular degeneration was performed in Argentina, LEH Pharma announced in a press release.

Hugo Nano, MD, of Buenos Aires, implanted the lens in both eyes of the patient. The device is delivered during cataract surgery and helps to improve vision in patients with wet or dry AMD, the release said.

“It is wonderful to have brought the EyeMax Mono lens into Argentina for the first time. The operation was a success, and this patient will be the first of many to have their quality of life improved by LEH Pharma’s technology,” Nano said in the release. “AMD is one of the main causes of vision loss in the Argentinian population, so it is exciting to see this new treatment option become available through such a straightforward, quick operation.”

The EyeMax Mono lens is approved for sale and has a CE mark in 34 countries internationally and has been implanted in more than 25 countries, according to the release.